Your browser doesn't support javascript.
loading
Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.
Garofalo, Michela; Romano, Giulia; Di Leva, Gianpiero; Nuovo, Gerard; Jeon, Young-Jun; Ngankeu, Apollinaire; Sun, Jin; Lovat, Francesca; Alder, Hansjuerg; Condorelli, Gerolama; Engelman, Jeffrey A; Ono, Mayumi; Rho, Jin Kyung; Cascione, Luciano; Volinia, Stefano; Nephew, Kenneth P; Croce, Carlo M.
Afiliación
  • Garofalo M; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Romano G; Istituto Di Ricovero e Cura a Carattere Scientifico Studio Diagnostica Nucleare (SDN), Naples, Italy.
  • Di Leva G; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Nuovo G; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Jeon YJ; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Ngankeu A; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Sun J; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Lovat F; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Alder H; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Condorelli G; Department of Cellular and Molecular Biology and Pathology, Institute of Experimental Endocrinology and Oncology, Consiglio Nazionale delle Ricerche (IEOS-CNR), Faculty of Biotechnological Science, 'Federico II' University of Naples, Napoli, Italy.
  • Engelman JA; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Ono M; Department of Pharmaceutical Oncology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
  • Rho JK; Department of Pulmonary and Critical Care Medicine, University of Ulsan, Seoul, Korea.
  • Cascione L; Department of Clinical and Molecular Biomedicine, University of Catania, Catania, Italy.
  • Volinia S; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA.
  • Nephew KP; Department of Cellular and Integrated Physiology, Medical Sciences Program, Indiana University School of Medicine and the Indiana University Simon Cancer Center, Bloomington, Indiana, USA.
  • Croce CM; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA. carlo.croce@osumc.edu.
Nat Med ; 28(11): 2436, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36195688
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos